Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Sorbello

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Biomedical Semantics|May 5, 2015
Exploring adverse drug events at the class levelRainer Winnenburg, Alfred Sorbello, Olivier Bodenreider
Annals of Neurology|January 21, 2014
Reply: To PMID 24242357Andrew J Fine, Alfred Sorbello, Cindy Kortepeter
Drug Safety|September 2, 2011
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature reviewS Christopher Jones, Alfred Sorbello, Robert M Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Registration trials of antibacterial drugs for the treatment of nosocomial pneumoniaAlfred Sorbello, Scott Komo, Thamban Valappil, et al.
Annals of Neurology|November 19, 2013
Progressive multifocal leukoencephalopathy after natalizumab discontinuationAndrew J Fine, Alfred Sorbello, Cindy Kortepeter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patientsAndrew J Fine, Alfred Sorbello, Cindy Kortepeter, et al.
Pharmacoepidemiology and Drug Safety|August 22, 2013
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactionsS Christopher Jones, Daniel S Budnitz, Alfred Sorbello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Reply to Ison et AlAlfred Sorbello, S Christopher Jones, Debra Birnkrant, et al.
Current Opinion in HIV and AIDS|June 1, 2012
Current advances in pharmacovigilance in the USA and Europe: meeting the challenges of safety monitoring in HIVKendall A Marcus, Alfred Sorbello, Melissa Truffa, et al.
Journal of Biomedical Informatics|September 7, 2015
Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategiesRainer Winnenburg, Alfred Sorbello, Anna Ripple, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Biomedical Semantics|May 5, 2015
Exploring adverse drug events at the class levelRainer Winnenburg, Alfred Sorbello, Olivier Bodenreider
Annals of Neurology|January 21, 2014
Reply: To PMID 24242357Andrew J Fine, Alfred Sorbello, Cindy Kortepeter
Drug Safety|September 2, 2011
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature reviewS Christopher Jones, Alfred Sorbello, Robert M Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Registration trials of antibacterial drugs for the treatment of nosocomial pneumoniaAlfred Sorbello, Scott Komo, Thamban Valappil, et al.
Annals of Neurology|November 19, 2013
Progressive multifocal leukoencephalopathy after natalizumab discontinuationAndrew J Fine, Alfred Sorbello, Cindy Kortepeter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patientsAndrew J Fine, Alfred Sorbello, Cindy Kortepeter, et al.
Pharmacoepidemiology and Drug Safety|August 22, 2013
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactionsS Christopher Jones, Daniel S Budnitz, Alfred Sorbello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Reply to Ison et AlAlfred Sorbello, S Christopher Jones, Debra Birnkrant, et al.
Current Opinion in HIV and AIDS|June 1, 2012
Current advances in pharmacovigilance in the USA and Europe: meeting the challenges of safety monitoring in HIVKendall A Marcus, Alfred Sorbello, Melissa Truffa, et al.
Journal of Biomedical Informatics|September 7, 2015
Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategiesRainer Winnenburg, Alfred Sorbello, Anna Ripple, et al.
Pageof 3